MicroRNA-647 targets SRF-MYH9 axis to suppress invasion and metastasis of gastric cancer: Erratum
Gengtai Ye(Southern Medical University), Xiaolong Qi(Zhongda Hospital Southeast University), Baoxiong Zhuang(Nanfang Hospital), Haipeng Zhou(Nanfang Hospital), Qingbin Yang(Key Laboratory of Guangdong Province), G Li(University of British Columbia), Zhiyong Shen(Nanfang Hospital), Liying Zhao(Nanfang Hospital), Yuming Jiang(Wake Forest University), Da Wang(Nanfang Hospital), Lei Zhang(Chinese Academy of Sciences), Yan Li(Southern Medical University), Xianjun Zhu(University of Electronic Science and Technology of China), Jiang Yu(Southern Medical University), Hao Liu(Shihezi University), Haijun Deng(Nanfang Hospital), Yanfeng Hu(Nanfang Hospital), Kunzhai Huang(Nanfang Hospital), Wende Li(Lanzhou Jiaotong University)
Cited by 4
Related Papers
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis
|Theranostics|2020|204
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
|The Lancet Oncology|2021|184
Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer
|Annals of Oncology|2020|175